Cambridge Heart, Inc. Expands Co-Marketing Agreement with St. Jude Medical

BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), today announced it has amended its sales and marketing agreement with St. Jude Medical (NYSE: SJM). St. Jude Medical’s sales force now will be able to market Cambridge Heart’s HearTwave® II Microvolt Alternans test to North American primary care and internal medicine physicians. In addition, Cambridge Heart’s sales force now will have the ability to support St. Jude Medical’s field sales force in all physician markets in North America. Under the original agreement, signed March 21, 2007, the cardiology and electrophysiology markets were to be targeted by St. Jude Medical’s field force, and Cambridge Heart’s representatives addressed the internal medicine and primary care markets.
MORE ON THIS TOPIC